A comparative study between low dose anti-thymocyte globulin versus basiliximab as induction therapy for standard immunologic risk kidney transplant patients

被引：0
作者：
David, Paolo Miguel [1 ]
Pamugas, Glenda Eleanor P. [1 ]
机构：
[1] Natl Kidney & Transplant Inst, Adult Nephrol, Quezon City, Philippines
来源：
TRANSPLANTATION | 2016年 / 100卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
420.11
引用
收藏
页码：S166 / S166
页数：1
相关论文
共 13 条
  • [1] Andress, 2014, TRANSPLANT RES MANAG, V6
  • [2] Atlani, 2013, SAUDI J KIDNEY DIS T, V24
  • [3] Brennan, 2006, NEW ENGLAND J MED, V355
  • [4] Chen Guodong, 2013, EXP CLIN TRANSPLANT, V11
  • [5] Djamali, 2000, TRANSPLANTATION, V69
  • [6] Immunophenotyping and Efficacy of Low Dose ATG in Non-Sensitized Kidney Recipients Undergoing Early Steroid Withdrawal: A Randomized Pilot Study
    Grafals, Monica
    Smith, Brian
    Murakami, Naoka
    Trabucco, Agnes
    Hamill, Katherine
    Marangos, Erick
    Gilligan, Hannah
    Pomfret, Elizabeth A.
    Pomposelli, James J.
    Simpson, Mary A.
    Azzi, Jamil
    Najafian, Nader
    Riella, Leonardo V.
    [J]. PLOS ONE, 2014, 9 (08):
  • [7] Thymoglobulin Induction Dosing Strategies in a Low-Risk Kidney Transplant Population: Three or Four Days?
    Hardinger, Karen L.
    Rasu, Rafia S.
    Skelton, Rebecca
    Miller, Brent W.
    Brennan, Daniel C.
    [J]. JOURNAL OF TRANSPLANTATION, 2010, 2010
  • [8] Issa, 2009, OXFORD J CLIN INF DI, V48
  • [9] Kesiraju, 2014, SAUDI J KIDNEY DIS T, V25
  • [10] Mothy, 2014, NEW DIRECTONS RABBIT
12